Antalpha price target lowered to $12 from $18.50 at Roth Capital

Roth Capital lowered the firm’s price target on Antalpha (ANTA) to $12 from $18.50 and keeps a Buy rating on the shares. Q1 guidance “looks soft,” says the analyst, who trims estimates following the company’s Q4 report.